References for: association

Full identifier: http://purl.org/np/RAAwl-RZMcLYiE6kpE5rJsvqr8sU2M0gcvV--CwWsRpRc#association

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Vincent Emonet
2022-09-16T11:55:46.573Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Vincent Emonet
2022-09-16T11:55:46.573Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Vincent Emonet
2022-09-16T11:55:46.573Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Vincent Emonet
2022-09-16T11:55:46.573Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Vincent Emonet
2022-09-16T11:55:46.573Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Vincent Emonet
2022-09-16T11:55:46.573Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Vincent Emonet
2022-09-16T11:55:46.573Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
In our study, extended-release dextroamphetamine-containing medications represented 8% (180/2233) of the overall off-label prescribing in children 3 to 5 years old and, as with methylphenidate, larger doses (25–30 mg) of dextroamphetamine were noted.
Vincent Emonet
2022-09-16T11:55:46.573Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Vincent Emonet
2022-09-16T11:55:46.573Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Vincent Emonet
2022-09-16T11:55:46.573Z